A Comparison of Intra-op Ketamine vs Placebo in Patients Having Spinal Fusion
NCT02424591
Completed
Postoperative pain is severe after major spine surgery. Opioids such as morphine and hydromorphone are routinely used for postoperative pain control. These drugs have significant side effects, most importantly respiratory depression, nausea, constipation and tolerance. Moreover, many spine surgery patients have used opioid pain medication for back pain long term, leading to pre-surgical opioid tolerance and increased postoperative pain. This has led to a search for adjuvant medications to reduce... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/19/2017
Locations: NYU School of Medicine, New York, New York
Conditions: Postoperative Pain
Register for Updates
Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions
NCT00596050
Completed
There are multiple retrospective studies detailing the use of etomidate in pediatric procedural sedation but few to no prospective clinical trials. None have compared etomidate to ketamine, currently the most commonly used sedative in the emergency department for pediatric procedural sedation. The investigators propose a randomized, controlled trial comparing etomidate versus ketamine for procedural sedation for fracture reduction for children presenting with extremity fracture requiring sedatio... Read More
Gender:
ALL
Ages:
Between 5 years and 18 years
Trial Updated:
05/08/2017
Locations: St. Christopher's Hospital for Children, Philadelphia, Pennsylvania
Conditions: Conscious Sedation Failure During Procedure
Register for Updates
Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery
NCT01983020
Completed
This study has been designed as a controlled clinical trial to evaluate the efficacy of brief lidocaine infusion, brief ketamine infusion and a lidocaine/ketamine combined infusion when added to conventional opioid therapy following major spine surgery, as well as to evaluate the effects of the lidocaine/ketamine pain protocol on the feasibility of performing routine intraoperative neurophysiology during spine surgery in adults and determine whether this infusion protocol is compatible with intr... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/28/2017
Locations: Beth Israel Medical Center, New York, New York
Conditions: Postoperative Pain
Register for Updates
N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression
NCT01260649
Terminated
Electroconvulsive therapy (ECT), is considered the most effective treatment for severe treatment resistant major depressive disorder (MDD), but it requires about 3 weeks of treatments and can cause considerable acute deficits in memory. It would be a major advance in treatment if ECT could work faster with fewer treatments and result in decrease incidence of memory problems. Ketamine is an excellent candidate for augmentation of ECT because of its acute effects on depression, its short half-life... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
04/18/2017
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Major Depressive Disorder
Register for Updates
Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder
NCT01667926
Completed
Ketamine infusions resulted in an acute reduction in global depression scores and in severity of suicidal ideation. The investigators therefore plan to investigate the feasibility and efficacy of repeated intravenous administration of ketamine in severely depressed, treatment resistant patients. The results of the study could lead to development of new strategies for treating depression.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
04/18/2017
Locations: Depression Clinical and Reseach Program - MGH, Boston, Massachusetts
Conditions: Major Depressive Disorder
Register for Updates
Ketamine Infusion for Treatment-resistant Major Depressive Disorder
NCT01582945
Completed
Ketamine infusion has been shown to have rapid antidepressant properties, however the possible use of ketamine in treatment-resistant depression as augmentation has not been investigated. The overall aim of this study is to assess the feasibility, safety and tolerability, efficacy and duration of the effect of intravenous N-methyl-D-aspartate antagonist ketamine as augmentation of antidepressants for chronic suicidal ideation in subjects with severe treatment-resistant depression (TRD). This is... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
04/18/2017
Locations: Depression Clinical and Research Program - MGH, Boston, Massachusetts
Conditions: Major Depressive Disorder
Register for Updates
Treatment Study of Bipolar Depression
NCT00947791
Terminated
The purpose of this study is to determine whether a single intravenous administration of an N-methyl-D-aspartate antagonist is safe and effective for the acute treatment of bipolar depression.
Gender:
ALL
Ages:
Between 21 years and 70 years
Trial Updated:
04/11/2017
Locations: Mount Sinai School of Medicine, New York, New York
Conditions: Bipolar Disorder
Register for Updates
Treatment of Suicidal Ideation With Intravenous Ketamine Infusion
NCT01887990
Completed
This study is dedicated to achieving better treatments for suicidal thoughts. Specifically, the investigators are studying the effect of a medication called ketamine to quickly treat suicidal thoughts and depression.
Gender:
ALL
Ages:
19 years and above
Trial Updated:
04/07/2017
Locations: University of Alabama Birmingham, Birmingham, Alabama
Conditions: Depression, Suicidal Ideation
Register for Updates
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
NCT02234011
Terminated
This study is being done to learn whether administration of intranasal (inhaled through the nose) ketamine reduces symptoms of obsessive-compulsive disorder (OCD). Ketamine has been approved by the U.S. Food and Drug Administration (FDA) as an anesthetic agent (a medicine to reduce pain during surgery and other procedures) but ketamine has not been approved by the FDA as a treatment for OCD. The investigators believe that ketamine may be effective in reducing symptoms of OCD due to its ability... Read More
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
04/05/2017
Locations: McLean Hospital, Belmont, Massachusetts
Conditions: Obsessive-Compulsive Disorder
Register for Updates
Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD
NCT02206776
Terminated
Obsessive-compulsive disorder (OCD) is a common illness that causes significant distress and impairment. Currently, serotonin reuptake inhibitors (SRIs) are the only medications that are FDA-approved to treat OCD. Unfortunately, SRIs can take a long time to work (2-3 months), and even then they usually only partially reduce OCD symptoms. The present study, will test if intranasal ketamine is feasible to use and can reduce OCD symptoms significantly more than a comparison medication called midazo... Read More
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
03/30/2017
Locations: New York State Psychiatric Institute, New York, New York
Conditions: Obsessive-Compulsive Disorder
Register for Updates
IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D
NCT02635282
Completed
The general objective of this study is to determine whether intranasal ketamine should be incorporated into formulary as an option to treat pain during minor procedures in the pediatric emergency department.
Gender:
ALL
Ages:
Between 3 years and 17 years
Trial Updated:
03/23/2017
Locations: Le Bonheur Children's Hospital, Memphis, Tennessee
Conditions: Abscess, Pain
Register for Updates
Anesthesia and Functional Connectivity: An Analysis of fMRI Changes
NCT02196259
Terminated
Functional connectivity is defined as a correlation in neural activity between distinct regions of the brain. Several recent studies have demonstrated areas of low-frequency functional connectivity inherent to brain tissue at rest. These oscillations can be measured using functional magnetic resonance imaging (fMRI) and appear to be synchronized between related areas of the brain. To date, no investigators have examined the effects of low-dose anesthesia on functional connectivity. This study w... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
03/21/2017
Locations: University of Michigan - fMRI Laboratory, Ann Arbor, Michigan
Conditions: Changes in Brain Network Connectivity
Register for Updates